Executive director Sherry Keramidas offers her views on the regulatory profession, the world they work in and the challenges they face in their careers.
As this year comes to a close, I took a little time to reflect on the challenges of the past year—and there were many. I find it useful to contemplate how these challenges may create opportunities for the year ahead. Let’s consider a few.
Economic issues rippled around the world and many governments are grappling with aging populations, increases in chronic disease and escalating health costs. Businesses are also facing changes in their models—from shifts in the sources of research and development to increasingly global supply chains, more-complex manufacturing systems and changes in overall funding and revenue streams. In the healthcare product sector, we have seen increased merger and acquisition activity, and continued political and public pressures stemming from consumer expectations of faster access to better products while eliminating risk.
